Connect Sign In
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.
American Society for Clinical Pathology (ASCP)
Atlanta, GA, November 17–20, 2025
Nelson HA—Presentation
Sandoval C, Nelson HA. Plasma-based diagnostics for Alzheimer's evaluation: navigating an evolving landscape.
Hird K—Poster
Hird K, Sakr R, Goodwill V, Hansen L, Trivedi U, Robinson A, Lei L. Synchronous olfactory neuroblastoma and olfactory carcinoma with genetic evidence of common clonal origin: a case report.
American Medical Informatics Association (AMIA)
Atlanta, GA, November 15–19, 2025
Rychert J—Presentation
Rallins M, Skapik J, Rychert J, Banning P, Emrick S. SHIELD as a mechanism to support the adoption of LOINC and SNOMED CT standards for laboratory data interoperability.
Association for Molecular Pathology (AMP)
Boston, MA, November 11–15, 2025
Reading NS, Deshotel MJ, Frederickson E, Close D, Ji Y—Poster
Reading NS, Deshotel MJ, Frederickson E, Close D, Ji Y. Use of long-range sequencing in carrier screening: a single-site evaluation.
Bui H, Lewis T, Joe S, Deshotel M, Pattison D, Yang L, Kellogg A, Kazan J, Fredrickson E, Rindler P, Bolia A, Pizzo L, Mao R, Andersen EF, Best H—Poster
Bui H, Lewis T, Joe S, Deshotel M, Pattison D, Yang L, Kellogg A, Kazan J, Fredrickson E, Rindler P, Bolia A, Pizzo L, Mao R, Andersen EF, Best H. Analytical validation of germline variant classes using PCR-free whole genome sequencing.
Liew M, Schumacher J, Ly D, Hellwig S, Shestakova A, George T, Li P—Poster
Liew M, Schumacher J, Tsewang T, Ly D, Hellwig S, Shestakova A, Berthier E, George T, Li P. Validation of a patient-centric collection technology for ddPCR detection of the KITD816V mutation.
NSGC National Society of Genetic Counselors
Seattle, WA, November 7–10, 2025
Openshaw AS, Rudd MK—Poster
Openshaw AS, Rudd MK. Additional cell counts do not usually identify low-level mosaicism in amniotic fluid after atypical mosaic cfDNA screening results.
American Society of Nephrology
Houston, TX, November 5–9, 2025
Bajaj AO, Kushnir MM, McMillin GA, Doyle K—Presentation
Akramimoghaddam F, Boucher R, Bajaj AO, Kushnir MM, McMillin GA, Doyle K, Beddhu S. Associations of plasma ceramides with adipose tissue, plasma and urinary markers of inflammation and oxidative stress in CKD.
ESGCP and ESGITM Parasite Morphology Hub Webinar Series
Salt Lake City, UT [live, virtual], October 30, 2025
Mathison BA—Presentation
Mathison BA. Worms I have known: weird/esoteric cases involving histology.
National Association of Medical Examiners
Louisville, KY, October 17–21, 2025
Schmitt J—Poster
Schmitt J, Marsden L, Duncanson ER, Mackey-Bojack S, Krehbiel KA. Left ventricular-dominant arrhythmogenic cardiomyopathy, active phase: two case reports highlighting genetic and pathologic insights.
California Association for Medical Laboratory Technology Annual Meeting
Sacramento, CA, October 17–18, 2025
Nelson HA—Presentation
Nelson HA. Advancing Alzheimer’s diagnosis: the role of fluid biomarkers and plasma pTau217.
American Society of Human Genetics (ASHG)
Boston, MA, October 14–18, 2025
Lewis ZK, Pizzo L, Clayton A, Hong B, Zhao J, Rudd K, Andersen EF—Poster
Lewis ZK, Pizzo L, Clayton A, Hong B, Zhao J, Rudd K, Andersen EF. Secondary findings in clinical genomic microarray – reporting strategies and experiences from constitutional and oncology settings.
Pizzo L, Lewis ZK, Reich D, Andersen EF—Poster
Pizzo L, Lewis ZK, Reich D, Andersen EF. Classifying non-coding structural variants for clinical genomics.
International Clinical Cytometry Society (ICCS)
Philadelphia, PA, September 28–30, 2025
Davis PM, Cherrington WH, Ng DP, Jacobsen JR—Poster
Davis PM, Cherrington WH, Ng DP, Jacobsen JR. Evaluation of Stage 0 Hematogones Using a 28-Marker Spectral B-cell Lymphoblastic Leukemia Panel.
Ravkov EV, De Juan JD, Gudipaty S, Abbott GV, Lin L—Poster
Ravkov EV, De Juan JD, Gudipaty S, Abbott GV, Lin L. Conversion of lymphocyte subsets assay from 3 to 1 tube format.
8th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma
New York, NY, September 26–28, 2025
Daines J, Szankasi P, Menon M, Jacobsen JR, Miles RR—Poster
Daines J, Ghosh T, Mims L, Szankasi P, Menon M, Jacobsen JR, Miles RR. EBV-Positive Gray Zone Lymphoma In A Pediatric Patient.
Mass Spectrometry: Applications to the Clinical Laboratory (MSACL)
Montreal, Canada, September 21–26, 2025
Kushnir MM—Presentation
Liang Z, Wu Y, Kushnir MM, Yang YK. Bioinformatics Pipeline for Targeted Glycosylation Profiling in Intact Protein Mass Spectrometry.
Kushnir MM—Presentation
Kushnir MM, Salihovic S, Bergquist J, Lind PM, Lind L. Environmental Pollutants and Sex Hormones in Elderly: A Cross-Sectional Population Study.
Kushnir MM—Presentation
Thorsteinsdóttir M, Eiriksson FF, Kushnir MM. Design of Experiments for Optimization of LC-MS Clinical Assays.
Schramm K, Ray JA, Kushnir MM, Yuzyuk T—Poster
Schramm K, Ray JA, Kushnir MM, Vachali P, Yuzyuk T. Monitoring UDCA and other Bile Acids in Intrahepatic Cholestasis of Pregnancy may improve clinical outcomes.
Ray JA, Merrigan SD, McMillin G, Fisher MA, Johnson Davis KL—Presentation
Ray JA, Merrigan SD, Vachali P, Bates T, Aventura Z, Putnam S, McMillin G, Fisher MA, Johnson Davis KL. A Proof-of Concept Study: Measuring Antifungals in Human Serum Using Direct Analysis in Real Time-Mass Spectrometry (DART-MS).
Smith D, Hughs M, McMillin G, Boyd J—Presentation
Smith D, Hughs M, McMillin G, Boyd J. Quantitation of perfluoroalkyl compounds in human serum/plasma by LC/MS/MS.
Ray JA—Presentation
Ray JA. A proof-of-concept study: measuring antifungals in human serum using direct analysis in real time-mass spectrometry (DART-MS).
Jensen MS, Pasquali M—Poster
Jensen MS, Pasquali M. Impact of collection tube type on amino acid concentration: plasma and serum.
Merrigan SD, Kushnir MM, and Frank EL—Poster
Merrigan SD, Kushnir MM, and Frank EL. Quantification of plasma nicotinic acid and two metabolites by LC-MS/MS.
Bajaj AO, Kushnir MM, Doyle K—Poster
Bajaj AO, Kushnir MM, Vachali P, Steckel S, McMillin G, Doyle K. Quantitative LC-MS/MS assay for ceramides in plasma and serum: development, validation, and performance evaluation.
Northeast Association for Clinical Microbiology and Infectious Diseases (NACMID)
Nashua, NH, September 21–26, 2025
Mathison BA—Presentation
Mathison BA. Laboratory Identification of Blood Parasites.
European Competence Network on Mastocytosis
London, United Kingdom, September 18–20, 2025
George TI—Presentation
George TI, Schwaab J. Prognostication and efficacy of novel TKIs in SM.
George TI, Rets A, Patel J, Menon M, Moser K—Presentation
George TI, Rets A, Patel J, Menon M, Moser K. Histopathological and phenotypic changes of mast cells during TKI therapy.
Society for Hematopathology and European Association for Hematopathology
Cincinnati, OH, September 4–6, 2025
Miles RR, Jacobsen JR, Smock KJ—Presentation
Miles RR, Jacobsen JR, Smock KJ, Cessna MH, Dewyze L, Taylor A. Acute megakaryoblastic leukemia with GATA1 mutation.
Southwestern Association of Clinical Microbiology
Dallas, TX, September 3–5, 2025
Mathison BA—Presentation
Mathison BA. Diagnostic Parasitology Algorithms.
International Congress of Inborn Errors of Metabolism (ICIEM)
Kyoto, Japan, September 2–6, 2025
Pasquali M, Saffary Y—Poster
Pasquali M, Saffary Y, Ames E, Fisher R, Maegawa G, Botto L, Longo N. Chondroitin sulfate non-reducing ends for the diagnosis of the slowly progressive form of mucopolysaccharidosis type 4A.
Association of Medical Laboratory Immunologists (AMLI)
Minneapolis, MN, August 14–17, 2025
Ghazaryan A, Saadalla A—Poster
Ghazaryan A, Abou-Ismail MY, Saadalla A. Persistence of Criteria Antiphospholipid Antibodies in Relation to Titers, Isotype and Antiphospholipid Syndrome diagnosis.
Martins TB, Toninelli MT, Peterson LK—Poster
Martins TB, Toninelli MT, Peterson LK. Evaluation of the Clinical Performance of a Particle-based Multi-analyte Technology for the Detection of Myositis Specific Antibodies.
Profaizer T, Thompson M, Saadalla A, Lazar-Molnar E—Poster
Profaizer T, Pole A, Thompson M, Saadalla A, Lazar-Molnar E. Celiac disease risk stratification: correlation of HLA genotype and celiac-specific antibody positivity.
2025 Parasitology Workshop
Rochester, MN, August 15–16, 2025
Mathison BA—Presentation
Mathison BA. Arthropod Ectoparasites.
Mathison BA—Poster
Mathison BA. Blood Parasites Pt. 2.
Alzheimer's Association International Conference
Toronto, Canada, July 27–31, 2025
Nelson HA, Erickson JA, La'ulu SL, Cunningham SD, Doyle K—Poster
Nelson HA, Erickson JA, La'ulu SL, Cunningham SD, Doyle K. Analytical validation of plasma P-tau217 on the SP-X platform.
Nelson HA, La’ulu SL, Erickson JA, Cunningham SD, Doyle K—Poster
Nelson HA, La’ulu SL, Erickson JA, Cunningham SD, Doyle K. Clinical validation of a plasma P-tau217 immunoassay and evaluation of the impact of kidney function.
Association for Diagnostics & Laboratory Medicine (ADLM)
Chicago, IL, July 27–31, 2025
Boyd JM—Presentation
Boyd JM. Analytical and clinical challenges of urine fentanyl testing by mass spectrometry: The reference laboratory perspective.
Schramm K, Ray JA, Kushnir MM, Yuzyuk T—Poster
Schramm K, Ray JA, Kushnir MM, Vachali P, Yuzyuk T. On importance of monitoring UDCA treatment in Intrahepatic Cholestasis of Pregnancy.
Jackson AN, La’ulu SL, Rudolf JW, Johnson-Davis KL, Boyd JM—Poster
Jackson AN, La’ulu SL, Rudolf JW, Johnson-Davis KL, Boyd JM. Evaluation of Immunalysis Carisoprodol Metabolite / Meprobamate Urine Homogeneous Enzyme Immunoassay (HEIA) on the AU5800.
Lu J, La'ulu S, Doyle K—Poster
Lu J, La'ulu S, Doyle K. Evaluation of an In-House Cholinesterase Assay for Serum, Plasma, and Whole Blood.
Lu J, La'ulu S, Doyle K—Poster
Lu J, La'ulu S, Doyle K. Validation of a Copeptin Immunoassay as a Surrogate for Vasopressin Testing.
Allison TA, La'ulu SL, Hunsaker JJH, Doyle K, Nelson HA—Poster
Allison TA, La'ulu SL, Hunsaker JJH, Doyle K, Nelson HA. Validation of Alzheimer’s Disease Markers in CSF.
Law R, Wyness S, La'ulu SL, Pandya V—Presentation
Law R, Wyness S, La'ulu SL, Pandya V. Evaluation of Stanbio Laboratory β-Hydroxybutyrate using the Abbott Alinity c Analyzer.
Erickson JA, La'ulu SL, Cunningham SD, Doyle K, Nelson HA—Poster
Erickson JA, La'ulu SL, Cunningham SD, Doyle K, Nelson HA. Performance Validation of a Plasma-Based Immunoassay for P-tau217.
Erickson JA, La'ulu SL, Nelson HA, Doyle K—Poster
Erickson JA, La'ulu SL, Nelson HA, Doyle K. Performance evaluation of an automated test system for determining the soluble fms-like tyrosine kinase/placental growth factor ratio.
Villanueva MG, Law RN, La'ulu SL, Wyness SP, Pandya V—Poster
Villanueva MG, Law RN, La'ulu SL, Wyness SP, Pandya V. Evaluation of Activated Aspartate Aminotransferase (A-AST) Assay using the Abbott Alinity c and Architect c4000.
Udechukwu MC, Doyle K—Poster
Udechukwu MC, Doyle K. Evaluation of the Relationship Between H-Index- and Hemoglobin-Normalized Glucose-6-Phosphate Dehydrogenase and Pyruvate Kinase Activities.
Hunsaker JJH, Villanueva MG, Billones R, La'ulu SL, Moss TJ, Merrell M, Straseski JA—Poster
Hunsaker JJH, Villanueva MG, Billones R, La'ulu SL, Moss TJ, Merrell M, Straseski JA. Validation of the Diagnostics Biochem Canada Vasoactive Intestinal Peptide (VIP) ELISA.
James Cook University Master of Public Health Course TM5503 Lecture Series
Townsville, Australia, June 30, 2025
Mathison BA—Presentation
Mathison BA. Autochthonous Paragonimiasis in the U.S.A.
American Society for Microbiology (ASM)
Los Angeles, CA, June 19–23, 2025
Wellems D, Hymas W, Hanson K—Poster
Wellems D, Hymas W, Hanson K. Evaluation of a Multiplex Panel for the Molecular Detection of Fungal Pathogens.
Mathison BA—Presentation
Mathison BA. Weirdobacters: Waiter, There's a Worm in my Eye!
Mathison BA—Presentation
Mathison BA. Histopathology of Parasitic Infections: Worms and Whatchamacallits.
Academy of Clinical Laboratory Physicians and Scientists (ACLPS)
Atlanta, GA, May 29–31, 2025
Udechukwu MC, Pandya V—Presentation
Udechukwu MC, Kevin S, Pandya V. Beyond Black and White: Performance of eGFR equations in a South Asian Cohort in the United States.
Harris HT, Shakir SM—Presentation
Harris HT, Shakir SM. Comparative Analysis of the Diagnostic Performance of Vaginitis Molecular Assays.
In-person LIVE Global Health Course—University of Minnesota
Minneapolis, MN, May 19–20, 2025
Mathison BA—Presentation
Pritt BS, Mathison BA. Stool Parasites Laboratory.
Mathison BA—Presentation
Pritt BS, Mathison BA. Blood Parasites Laboratory.
Mathison BA—Presentation
Mathison BA, Pritt BS. Ectoparasites Laboratory.
Mathison BA—Presentation
Mathison BA. Case Studies in Medical Entomology: A Field Guide to Arthropods of the Human Body.
American Society of Pediatric Hematology/Oncology
Louisville, KY, May 10, 2025
Miles RR—Presentation
Miles RR, Schwartz L, Stokke J, Welch J. When N=1, Diagnosing and Treating Rare Non-Hodgkin Lymphomas.
International Society for Laboratory Hematology (ISLH)
Halifax, Nova Scotia, Canada, May 7–10, 2025
Moser KA, Smock KJ—Poster
Moser KA, Smock KJ. HIT ELISA OD values demonstrate significant variability.
Smock KJ—Presentation
Smock KJ. Update on laboratory diagnosis of von Willebrand Disease.
Smock KJ—Presentation
Smock KJ. Changes impacting laboratory developed tests, a perspective.
APHL Annual Conference
Portland, OR, May 5–8, 2025
Mathison BA—Presentation
Mathison BA. Case Studies in Zoonotic Helminths.
Fairview Health Services Webinar
MN, May 5, 2025
Mathison BA—Presentation
Mathison BA. Morphologic Identification of Plasmodium and Babesia.
Rocky Mountain Section ALDM Spring Meeting
Salt Lake City, Utah, May 1–2, 2025
Udechukwu MC, Pandya V, Young BA—Poster
Udechukwu MC, Pandya V, Young BA. Performance Evaluation of Dräger Jaundice Meter JM-105 for Newborn Hyperbilirubinemia Screening.
Boyd JM, Smith D, Hughs M, McMillin GA—Poster
Boyd JM, Smith D, Hughs M, McMillin GA. Quantitation of Perfluoroalkyl Compounds in Human Serum/Plasma by LC/MS/MS.
Pasquali M, Saffary Y, Ingoglia F, Hobert J—Poster
Pasquali M, Saffary Y, Ingoglia F, Hobert J, Ames E, Fisher R, Maegawa G, Botto L, Longo N. Challenges in the diagnosis of mucopolysaccharidosis type 4A.
Nelson HA—Presentation
Nelson HA. Evolving Biomarker Testing Landscape in Alzheimer’s Disease.
Lu J, La'ulu S, Doyle K—Poster
Lu J, La'ulu S, Doyle K. Evaluation of an In-House Cholinesterase Assay for Serum, Plasma, and Whole Blood.
Law RN, Wyness SP, La'ulu SL, Pandya V—Poster
Law RN, Wyness SP, La'ulu SL, Pandya V. Evaluation of Stanbio Laboratory B-Hydroxybutyrate using the Abbott Alinity c Analyzer.
Allison TA, La'ulu SL, Hunsaker JJH, Doyle K, Nelson HA—Poster
Allison TA, La'ulu SL, Hunsaker JJH, Doyle K, Nelson HA. Validation of Alzheimer’s Disease Markers in CSF.
Villanueva MG, Law R, La'ulu SL, Wyness SP, Pandya V—Poster
Villanueva MG, Law R, La'ulu SL, Wyness SP, Pandya V. Evaluation of Activated Aspartate Aminotransferase (A-AST) Assay using the Abbott Alinity c and Architect c4000.
Jackson AN, La’ulu SL, Rudolf JW, Johnson-Davis KL, Boyd JM—Poster
Jackson AN, La’ulu SL, Rudolf JW, Johnson-Davis KL, Boyd JM. Evaluation of Immunalysis Carisoprodol Metabolite / Meprobamate Urine Homogeneous Enzyme Immunoassay (HEIA) on the AU5800.
Hunsaker JJH, Villanueva MG, Billones R, La'ulu SL, Moss TJ, Merrell M, Straseski JA—Poster
Hunsaker JJH, Villanueva MG, Billones R, La'ulu SL, Moss TJ, Merrell M, Straseski JA. Validation of the Diagnostics Biochem Canada Vasoactive Intestinal Peptide (VIP) ELISA.
